StockGlow

DexCom, Inc. (DC4.F)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.

71.40+0.11%Healthcare
Compare DC4.F with
StockGlow Score
94
Bullish
BearishBullish
1 year ago+1.4%

The outlook

DexCom, Inc. currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
$27.66B
52-wk high
73.40
52-wk low
46.88
50-day avg
63.42
200-day avg
58.07
Trailing P/E
32.3

Similar stocks

IUI1.FIntuitive Surgical, Inc.$306.85+1.27%VX1.FVertex Pharmaceuticals Incorporated$414.30+0.74%AFW.FAlign Technology, Inc.$150.95+4.61%ILU.FIllumina, Inc.$169.00+0.09%IDP.FBiogen Inc.$178.92+0.42%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy